欧洲骨科膝关节市场 – 行业趋势及 2029 年预测

市场分析和见解

膝盖是人体最大的关节。膝盖的上骨和下骨由两个椎间盘（半月板）隔开。大腿骨（股骨）和小腿骨（胫骨和腓骨）由韧带和肌腱连接。本文介绍了几种需要使用膝关节矫形器械（如膝关节植入物、矫形器和辅助器具）以及使用药物（如止痛药和非甾体抗炎药 (NSAID)）的原因。进行膝关节置换手术的常见原因是缓解由骨关节炎、关键韧带和侧韧带撕裂以及半月板损伤引起的剧烈疼痛。需要进行膝关节置换手术的人通常在行走、爬楼梯和上下椅子时会遇到困难。有些人在休息时也会感到膝盖疼痛。

市场定义

在欧洲，骨科疾病在全球范围内持续上升。欧洲常见的膝关节疾病是膝骨关节炎。膝骨关节炎占全球骨关节炎 (OA) 负担的近五分之四，并且随着肥胖和年龄的增长而增加。膝关节疾病，尤其是膝骨关节炎，是老年人群中常见的残疾的主要原因。到目前为止，膝骨关节炎已被证明是可以治愈的，但膝关节置换术除外，膝关节置换术被认为是晚期疾病的有效治疗方法。膝关节置换术包括切开和切除患者大腿骨和膝盖骨的受损骨骼，并用人工关节（假体和植入物）替换，人工关节是移动和固定轴承植入物。假体和植入物由金属、陶瓷和塑料组成。韧带的修复方法是将韧带放回其解剖位置的原始骨骼上，使用小锚将韧带固定在骨骼上。

Data Bridge Market Research 分析称，2022 年至 2029 年的预测期内，欧洲骨科膝关节市场将以 5.0% 的复合年增长率增长。

 Europe Orthopedic Knee Market Dynamics

Drivers

• Rise in incidence of knee diseases

Orthopedic diseases continue to rise throughout the globe. The typical knee disease which occurs in Europe is knee osteoarthritis. Knee osteoarthritis accounts for almost four-fifths of osteoarthritis (OA) burden worldwide and increases with obesity and age. Knee diseases, especially knee osteoarthritis, are common and a significant cause of disability among the elderly population. Knee osteoarthritis can be treated easily in Europe. In Europe, a survey conducted by e-clinical medicine states that the prevalence of knee diseases in Europe was 19.2%.

For instance,

• In March 2020, according to a report by the Oxford Academic, the incidence of knee osteoarthritis was reported to show the highest number of cases in the U.K., followed by France, Germany, Spain, and Italy, showing the fewer record cases of knee osteoarthritis

Knee osteoarthritis is a common occurrence in Switzerland. The rise in the incidence of chronic knee disorders is expected to boost the sales and supply of medication and implants for the treatment of knees in Europe. It is expected to meet the patient's requirements. The knowledge about the prevalence and incidence of orthopedic knee diseases would help find novel solutions and aid in more collaborations and partnerships with market players based in countries in Europe.

• Rise in awareness about knee treatment in Europe

Cognizance of knee disorders, understanding, and scope of the treatment is a vital step to help and guide people suffering from osteoarthritis and meniscal injuries. It helps in achieving early detection and management. Public and private institutes' awareness about the symptoms and treatment of chronic knee diseases would result in timely treatment and provide the option to access inexpensive universal health aid and increased availability of rehabilitative therapy

For instance,

• In November 2020, the European Knee Society (EKS) had collaborated with the Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Italy, for organizing two fellowships and creating awareness about the treatment of primary and revision knee and hip replacement

From the above points, we can establish that awareness about the early treatment and use of knee implants would result in collaborations of market players with health institutions for the supply and distribution of the devices. This will result in a rise in product and business line expansion.

Opportunities

• Strategic Initiatives By Market Players

The need for medications to treat knee disorders in Europe has increased due to the rise in prevalence and incidence of chronic knee disorders, advanced therapies for knee osteoarthritis and meniscal injuries, and unmet medical needs. The factors (such as rise in incidence, cases of chronic knee disorders, and availability of advanced therapies) enhance the necessity for orthopedic rehabilitation therapy, and to achieve the market demand, minor and major market players are utilizing various strategies.

The major players are also trying to devise specific strategies, such as product launches, acquisitions, approvals, expansions, and partnerships, to ensure the smooth running of the business, avoid risks, and increase the long-term growth in the sales of the market.

For instance,

• In June 2020, Zimmer Biomet received clearance from the Food and Drug Administration (FDA) for ROSA Hip System for Robotically-Assisted Direct Anterior Total Hip Arthroplasty. The clearance received had made the ROSA Hip System available for use by diagnostic centers in Europe and made it clear for post-marketing approval
• In December 2017, amplitude SURGICAL launched the ACLip, an innovation in anterior cruciate ligament (ACL) reconstruction knee surgery. The ACLip is a knee implant that provides surgeons an enhanced method to perform knee arthroscopy surgeries and is used as an outpatient procedure. The launch had increased the sales and revenue of the knee product segment, and the novel implant was distributed in orthopedic clinics in Europe

The growth of technological advancements in orthopedic knee implants

Total knee arthroplasty is a suitable treatment for severe osteoarthritis. Despite reasonable survival rates, up to 20% of real knee arthroplasty patients remain dissatisfied. Recently, promising new technologies have been developed in knee arthroplasty and could improve functional outcomes. The robotic-assisted systems allow an accurate and reproducible bone preparation due to robotic assistance, with a 3D surgical planning, based on preoperative 3D imaging or not.

For instance,

• In November 2021, Smith & Nephew launched the turnkey' robotic-assisted surgical system; an advanced system for total and partial knee arthroplasties. The turnkey robotic surgical system was designed to measure, plan, and perform a knee surgery that is personalized to the patient's anatomy

Novel technologies are expected to improve diagnosis, risk stratification, and disease monitoring of meniscal injuries and osteoarthritis. The innovative combined drug therapies are expected to improve patient outcomes in the coming years. Hence, the use of innovative treatments is expected to create lucrative opportunities for the Europe orthopedic knee market

Restraints/Challenges

• Problems Faced While Using Orthopedic Knee Medications and Implants

Orthopedic specialists observe certain risks while using the implants and consuming the medications. The knee replacement surgeries deliver complications that arise from surgery or a faulty implant. The implant becoming loose is one of the most severe complications after knee surgery, and pain is the most common one. Loosening can cause bone fractures, instability, and serious falls. Almost all serious complications require revision surgery. The risks faced are mechanical risks, knee implant loosening and physical pain.

For instance,

• The risks incurred while using the orthopedic ceramic knee implants are implant failure due to induced aseptic loosening and hypersensitivity
• The complications occurred in metal implants after surgery are loosening, instability, dislocation, misalignment, and device failure, which can result from manufacturing defects, poorly fitted implants, or problems during surgery

The risks that occur while using the knee implants and consuming the medication would decrease the usage and supply of the knee implants and bracing and supporting devices. This may lead to a decline in sales of implants and drugs. Therefore, the risks related to knee medications and implants are expected to hinder the market growth.

• Lack of skilled professionals

The lack or shortage of skilled expertise would challenge the pace of recovery and growth in one place. Often, the unemployed people in one place have skills that are in short supply elsewhere. Moreover, rapid technological advancement in this field also leads to a lack of expertise. Despite the call to increase, the number of podiatrists in Europe and several residency training programs remain unknown.

For instance,

• In England, the data by the National Center of Biotechnology Information (NCBI) state that joint arthroplasty service has substantially declined over recent weeks throughout Europe

As skill demands are too high, it has manifested as a challenge to retain and manage skill-specified professionals. Moreover, technological advancement is another aspect that leads to the increased demand for skilled professionals

The Europe orthopedic knee market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Europe orthopedic knee market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

The data by the Academic coup states that around four million people suffer from knee osteoarthritis, across Europe and has a lifetime risk of 45% for knee osteoarthritis.

Europe orthopedic knee market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on the Europe Orthopedic Knee Market

The COVID-19 has negatively affected the market. Lockdowns and isolation during pandemics complicate the diagnosis management and treatment. The lack of access to orthopaedic clinics will further affect the market. Social isolation increases stress, despair, and social support, all of which may cause a reduction in the treatment of chronic knee injuries during the pandemic.

Recent Development

• In March, DePuy Synthes had added two more orthopedic knee products in its portfolio, to the Attune knee portfolio, during the pandemic. The two products which were added are the cementless fixed bearing knee and medial stabilized knee to it’s attune knee portfolio. The addition of the new orthopedic knee products increased the product segment revenue and increased the market size in Europe region

Europe Orthopedic Knee Market Scope

The Europe orthopedic knee market is segmented on the basis of product type, indication and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Knee arthroscopy
• Ligament Repair
• Others

On the basis of product type, the market is segmented into knee arthroscopy, ligament repair and others.

Indication

• Osteoarthritis
• Cruciate And Collateral Ligament Tears
• Meniscal Injuries
• Others

根据适应症，市场细分为骨关节炎、十字韧带和侧副韧带撕裂、半月板损伤和其他

最终用户

• 医院
• 康复中心
• 骨科中心
• 门诊手术中心
• 其他的

根据最终用户，市场分为医院、康复中心、骨科中心、门诊手术中心和其他。

欧洲骨科膝关节市场区域分析/见解

如上所述，对欧洲骨科膝关节市场进行了分析，并按国家、产品类型、适应症和最终用户提供了市场规模洞察和趋势。

欧洲骨科膝关节市场报告涵盖的国家包括德国、法国、英国、西班牙、意大利、土耳其、荷兰、比利时、瑞士和欧洲其他地区。由于膝关节骨关节炎发病率上升、膝关节置换手术数量增加以及德国拥有多家骨科中心，预计德国将占据市场主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。

竞争格局和欧洲骨科膝关节市场份额分析

欧洲骨科膝关节市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对欧洲骨科膝关节市场的关注有关。

欧洲骨科膝关节市场的一些主要参与者包括 Smith & Nephew、Össur、OTTOBOCK、DePuy Synthes（强生私人有限公司的子公司）、GROUP FH ORTHO、Stryker、Zimmer Biomet.、B. Braun Melsungen AG、aap Implantate AG、MicroPort Orthopedics, Inc.、Exactech, Inc.、Medacta International、Aequos Endoprothetik GmbH、Symbios Orthopédie SA、PETER BREHM GmbH、Bayer AG、alloPlus GmbH、Bauerfeind USA Inc.、amplitude SURGICAL 和 CERAVER 等。

SKU-68177